{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:49:37Z","timestamp":1786132177246,"version":"build-2736575974"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Targeting stromal cells such as inflammatory fibroblasts presents a potential avenue to alleviate autoimmune inflammation and fibrosis. This study aimed to characterize LRRC15 expression in rheumatoid arthritis (RA) and systemic sclerosis (SSc) across fibroblast subsets and assess whether targeting LRRC15-expressing fibroblasts can be beneficial for the treatment of fibrosis and fibroblast-mediated inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted transcriptomic analyses of Lrrc15 in bulk and single-cell RNA-seq datasets from RA and SSc. We used flow cytometry, RNA-seq, immunohistochemistry and spatial transcriptomics to define Lrrc15 expression patterns in diseased tissues. We performed in vitro and in vivo assays to elucidate the function of LRRC15 in inflammatory fibroblasts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>When compared with healthy controls, we observed a higher activated fibroblast gene signature in RA synovium and SSc skin biopsies that correlated with Lrrc15 expression. Multi-IF imaging highlighted the clustering of LRRC15-expressing fibroblasts within tertiary lymphoid structures (TLS) in RA synovium. Knockdown of Lrrc15 in primary cells reduced production of TNF-\u03b1 induced inflammatory chemokines including CCL3 and CXCL10. We confirmed LRRC15 upregulation in mouse models of wound healing and pulmonary fibrosis. Inflammatory fibroblasts with high LRRC15 expression were susceptible to NK cell-mediated LRRC15 specific lysis in vitro.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Targeting LRRC15+ fibroblasts and fibrotic microenvironment may offer a new therapeutic opportunity to reduce inflammation in RA, SSc and other autoimmune disorders where activated fibroblasts play a role in disease pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag293","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:57:52Z","timestamp":1782302272000},"source":"Crossref","is-referenced-by-count":1,"title":["Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-5297","authenticated-orcid":false,"given":"Xintao","family":"Tu","sequence":"first","affiliation":[{"name":"Discovery Immunology, Merck & Co., Inc. , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao-Nguyen","family":"Bach","sequence":"additional","affiliation":[{"name":"Data, AI & Genome Sciences, Merck & Co., Inc. , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Baghela","sequence":"additional","affiliation":[{"name":"Data, AI & Genome Sciences, Merck & Co., Inc. , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zielstorff","sequence":"additional","affiliation":[{"name":"Quantitative Biosciences, Merck & Co., Inc. , Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Smallridge","sequence":"additional","affiliation":[{"name":"Non-clinical Drug Safety, Merck & Co., Inc. , Westpoint, PA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[{"name":"Discovery Cardiometabolic Disease, Merck & Co., Inc. , Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha","family":"Motlagh","sequence":"additional","affiliation":[{"name":"Discovery Biologics, Merck & Co., Inc. , South San Francisco, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Barr","sequence":"additional","affiliation":[{"name":"Discovery Cardiometabolic Disease, Merck & Co., Inc. , Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Alexander","family":"Sze","sequence":"additional","affiliation":[{"name":"Data, AI & Genome Sciences, Merck & Co., Inc. , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Sock","family":"Jang","sequence":"additional","affiliation":[{"name":"Data, AI & Genome Sciences, Merck & Co., Inc. , San Diego, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang-Hoover","sequence":"additional","affiliation":[{"name":"Quantitative Biosciences, Merck & Co., Inc. , Boston, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex M","family":"Tamburino","sequence":"additional","affiliation":[{"name":"Data, AI & Genome Sciences, Merck & Co., Inc. , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M","family":"Peterson","sequence":"additional","affiliation":[{"name":"Data, AI & Genome Sciences, Merck & Co., Inc. , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh V","family":"Kamath","sequence":"additional","affiliation":[{"name":"Discovery Immunology, Merck & Co., Inc. , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc C","family":"Levesque","sequence":"additional","affiliation":[{"name":"Discovery Immunology, Merck & Co., Inc. , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Vroom","sequence":"additional","affiliation":[{"name":"Discovery Biologics, Merck & Co., Inc. , South San Francisco, CA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Discovery Immunology, Merck & Co., Inc. , Cambridge, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2026062601165446600_keag293-B1","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1186\/1755-1536-5-s1-s18","article-title":"Fibrosis in systemic sclerosis: common and unique pathobiology","volume":"5","author":"Bhattacharyya","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"2026062601165446600_keag293-B2","doi-asserted-by":"publisher","first-page":"1376925","DOI":"10.3389\/fmed.2024.1376925","article-title":"Fibroblasts in rheumatoid arthritis: novel roles in joint inflammation and beyond","volume":"11","author":"Neofotistou-Themeli","year":"2024","journal-title":"Front Med"},{"key":"2026062601165446600_keag293-B3","doi-asserted-by":"publisher","first-page":"100841","DOI":"10.1016\/j.isci.2020.100841","article-title":"Principles of cell circuits for tissue repair and fibrosis","volume":"23","author":"Adler","year":"2020","journal-title":"iScience"},{"key":"2026062601165446600_keag293-B4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026062601165446600_keag293-B5","doi-asserted-by":"publisher","first-page":"e149538","DOI":"10.1172\/jci149538","article-title":"Fibroblast pathology in inflammatory diseases","volume":"131","author":"Wei","year":"2021","journal-title":"J Clin Investig."},{"key":"2026062601165446600_keag293-B6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"2026062601165446600_keag293-B7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"2026062601165446600_keag293-B8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3765","article-title":"Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis","volume":"9","author":"Lagares","year":"2017","journal-title":"Sci Transl Med"},{"key":"2026062601165446600_keag293-B9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","article-title":"Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases","volume":"16","author":"Hinz","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026062601165446600_keag293-B10","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.bbadis.2013.02.007","article-title":"Tissue mechanics and fibrosis","volume":"1832","author":"Wells","year":"2013","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"2026062601165446600_keag293-B11","doi-asserted-by":"publisher","first-page":"12681","DOI":"10.3390\/ijms222312681","article-title":"Fibroblast activation protein targeted photodynamic therapy selectively kills activated skin fibroblasts from systemic sclerosis patients and prevents tissue contraction","volume":"22","author":"Dorst","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026062601165446600_keag293-B12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41467-018-02892-y","article-title":"Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis","volume":"9","author":"Mizoguchi","year":"2018","journal-title":"Nat Commun"},{"key":"2026062601165446600_keag293-B13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","article-title":"LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity","volume":"611","author":"Krishnamurty","year":"2022","journal-title":"Nature"},{"key":"2026062601165446600_keag293-B14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","article-title":"Intra- and inter-cellular rewiring of the human colon during ulcerative colitis","volume":"178","author":"Smillie","year":"2019","journal-title":"Cell"},{"key":"2026062601165446600_keag293-B15","doi-asserted-by":"publisher","first-page":"e159566","DOI":"10.1172\/jci.insight.159566","article-title":"Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trial","volume":"7","author":"Khanna","year":"2022","journal-title":"JCI Insight."},{"key":"2026062601165446600_keag293-B16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","article-title":"Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis","volume":"19","author":"Bustamante","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2026062601165446600_keag293-B17","doi-asserted-by":"publisher","first-page":"e0183928","DOI":"10.1371\/journal.pone.0183928","article-title":"Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast\/plasma cell differentiation pathways","volume":"12","author":"Walsh","year":"2017","journal-title":"PLoS ONE"},{"key":"2026062601165446600_keag293-B18","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.4049\/jimmunol.1601988","article-title":"CD40L-dependent pathway is active at various stages of rheumatoid arthritis disease progression","volume":"198","author":"Guo","year":"2017","journal-title":"J Immunol"},{"key":"2026062601165446600_keag293-B19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/hum.2015.127","article-title":"Disease-regulated gene therapy with anti-inflammatory interleukin-10 under the control of the CXCL10 promoter for the treatment of rheumatoid arthritis","volume":"27","author":"Broeren","year":"2016","journal-title":"Hum Gene Ther"},{"key":"2026062601165446600_keag293-B20","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/ar4526","article-title":"Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation","volume":"16","author":"Woetzel","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"2026062601165446600_keag293-B21","doi-asserted-by":"publisher","first-page":"101130","DOI":"10.1016\/j.xcrm.2023.101130","article-title":"An agonistic anti-signal regulatory protein \u03b1 antibody for chronic inflammatory diseases","volume":"4","author":"Xie","year":"2023","journal-title":"Cell Rep Med"},{"key":"2026062601165446600_keag293-B22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","article-title":"Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes","volume":"623","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"2026062601165446600_keag293-B23","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"2026062601165446600_keag293-B24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/s0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"2026062601165446600_keag293-B25","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","article-title":"The pathogenesis of rheumatoid arthritis","volume":"55","author":"Alivernini","year":"2022","journal-title":"Immunity"},{"key":"2026062601165446600_keag293-B26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fmed.2017.00118","article-title":"Exploring animal models that resemble idiopathic pulmonary fibrosis","volume":"4","author":"Tashiro","year":"2017","journal-title":"Front Med"},{"key":"2026062601165446600_keag293-B27","doi-asserted-by":"publisher","first-page":"1759720X221114101","DOI":"10.1177\/1759720x221114101","article-title":"Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes","volume":"14","author":"Taylor","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2026062601165446600_keag293-B28","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41591-022-01789-0","article-title":"Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial","volume":"28","author":"Rivellese","year":"2022","journal-title":"Nat Med"},{"key":"2026062601165446600_keag293-B29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/ar4230","article-title":"Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells","volume":"15","author":"Gilbane","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2026062601165446600_keag293-B30","doi-asserted-by":"publisher","first-page":"1759720X211066686","DOI":"10.1177\/1759720x211066686","article-title":"The role of antifibrotic therapies in the treatment of systemic sclerosis\u2013associated interstitial lung disease","volume":"14","author":"Boleto","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2026062601165446600_keag293-B31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13073-022-01081-3","article-title":"Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritis","volume":"14","author":"Armaka","year":"2022","journal-title":"Genome Med"},{"key":"2026062601165446600_keag293-B32","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3389\/fimmu.2018.01952","article-title":"Tertiary lymphoid structures: autoimmunity goes local","volume":"9","author":"Pipi","year":"2018","journal-title":"Front Immunol"},{"key":"2026062601165446600_keag293-B33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026062601165446600_keag293-B34","doi-asserted-by":"publisher","first-page":"13490","DOI":"10.1073\/pnas.1905301116","article-title":"Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology","volume":"116","author":"Nayar","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026062601165446600_keag293-B35","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1158\/0008-5472.can-18-0327","article-title":"LRRC15 is a novel mesenchymal protein and stromal target for antibody\u2013drug conjugates","volume":"78","author":"Purcell","year":"2018","journal-title":"Cancer Res"},{"key":"2026062601165446600_keag293-B36","doi-asserted-by":"publisher","first-page":"e70220","DOI":"10.1002\/iid3.70220","article-title":"Leucine-rich repeat containing 15 promotes the inflammatory response in rheumatoid arthritis by regulating NF-\u03baB pathway","volume":"13","author":"Xin","year":"2025","journal-title":"Immun Inflamm Dis."},{"key":"2026062601165446600_keag293-B37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13075-025-03629-1","article-title":"Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15\/STAT3 signaling pathway","volume":"27","author":"Qiao","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"2026062601165446600_keag293-B38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jid.2024.06.1279","article-title":"The dual roles of leucine-rich repeat-containing protein 15 positive fibroblasts: from cancer to tissue repair","volume":"145","author":"Zhu","year":"2025","journal-title":"J Investig Dermatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag293\/68605662\/keag293.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/6\/keag293\/68605662\/keag293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/6\/keag293\/68605662\/keag293.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:16:59Z","timestamp":1782451019000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag293\/8715515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag293","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"keag293"}}